The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotective Response in Human Lung Cancer Cells
Open accessAbstract
Epidermal growth factor receptor tyrosine kinase inhibitors gefitinib and erlotinib have been widely used in patients with non-small-cell lung cancer. Unfortunately, the efficacy of EGFR-TKIs is limited because of natural and acquired resistance. As a novel cytoprotective mechanism for tumor cell to survive under unfavorable conditions, autophagy has been proposed to play a role in drug resistance of tumor cells. Whether autophagy can be activated by gefitinib or erlotinib and thereby impair the sensitivity of targeted therapy to lung cancer cells remains unknown. Here, we first report that gefitinib or erlotinib can induce a high level of autophagy, which was accompanied by the inhibition of the PI3K/Akt/mTOR signaling pathway. Moreover, cytotoxicity induced by gefitinib or erlotinib was greatly enhanced after autophagy inhibition by the pharmacological inhibitor chloroquine (CQ) and siRNAs targeting ATG5 and ATG7, the most important components for the formation of autophagosome. Interestingly, EGFR-TKIs can still induce cell autophagy even after EGFR expression was reduced by EGFR specific siRNAs. In conclusion, we found that autophagy can be activated by EGFR-TKIs in lung cancer cells and inhibition of autophagy augmented the growth inhibitory effect of EGFR-TKIs. Autophagy inhibition thus represents a promising approach to improve the efficacy of EGFR-TKIs in the treatment of patients with advanced non-small-cell lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kris, M. G., Natale, R. B., Herbst, R. S., Lynch, Jr., Prager, D., Belani, C. P., Schiller, J. H., Kelly, K., Spiridonidis, H., Sandler, A., et al. (2003) · JAMA · doi:10.1001/jama.290.16.2149 · Cited by 2,517
Autophagosome formation: core machinery and adaptations
Xie, Z., & Klionsky, D. J. (2007) · Nature Cell Biology · doi:10.1038/ncb1007-1102 · Cited by 2,164
Autophagy: from phenomenology to molecular understanding in less than a decade
Klionsky, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2245 · Cited by 1,934
Lung cancer in never smokers — a different disease
Sun, S., Schiller, J. H., & Gazdar, A. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2190 · Cited by 1,608
Hirsch, F. R., Varella-Garcia, M., Bunn, P. A., Di Maria, M. V., Veve, R., Bremnes, R. M., Barón, A. E., Zeng, C., & Franklin, W. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.069 · Cited by 1,477
Lysosomes and autophagy in cell death control
Kroemer, G., & Jäättelä, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1738 · Cited by 1,285
Autophagy and signaling: their role in cell survival and cell death
Codogno, P., & Meijer, A. J. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401751 · Cited by 1,092
Bellodi, C., Lidonnici, M. R., Hamilton, A., Helgason, G. V., Soliera, A. R., Ronchetti, M., Galavotti, S., Young, K. W., Selmi, T., Yacobi, R., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35660 · Cited by 570
Blocked Autophagy Sensitizes Resistant Carcinoma Cells to Radiation Therapy
Apel, A., Herr, I., Schwarz, H., Rodemann, H. P., & Mayer, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-0562 · Cited by 523
Dalby, K., Tekedereli, I., Lopez-Berestein, G., & Ozpolat, B. (2010) · Autophagy · doi:10.4161/auto.6.3.11625 · Cited by 446
EGFR Signaling and Drug Discovery
Lurje, G., & Lenz, H.-J. (2009) · Oncology · doi:10.1159/000279388 · Cited by 442
Nguyen, K.-S. H., Kobayashi, S., & Costa, D. B. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.039 · Cited by 437
One Hundred Years of Lung Cancer
Spiro, S. G., & Silvestri, G. A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-531oe · Cited by 379
Shikonin circumvents cancer drug resistance by induction of a necroptotic death
Han, W., Li, L., Qiu, S., Lu, Q., Pan, Q., Gu, Y., Luo, J., & Hu, X. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0511 · Cited by 364
Self-citationZhu, K., Dunner, K., & McConkey, D. J. (2010) · Oncogene · doi:10.1038/onc.2009.343 · Cited by 338 · cited 2×
“Recently, it was found that autophagy can be activated and protected tumor cells from targeted therapies, such as the imatinib mesylate in philadelphia chromosome–positive cells [18], trastuzumab in breast cancer [20], Src family kinase inhibitors in prostate cancer [35], proteasome inhibitors in prostate cancer [16].”
BackgroundCao, C., Subhawong, T., Albert, J. M., Kim, K. W., Geng, L., Sekhar, K. R., Gi, Y. J., & Lu, B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0802 · Cited by 332
The induction of autophagy by γ‐radiation contributes to the radioresistance of glioma stem cells
Lomonaco, S. L., Finniss, S., Xiang, C., DeCarvalho, A., Umansky, F., Kalkanis, S. N., Mikkelsen, T., & Brodie, C. (2009) · International Journal of Cancer · doi:10.1002/ijc.24402 · Cited by 322
Henson, E. S., & Gibson, S. B. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.05.015 · Cited by 300
To Die or Not to Die: That is the Autophagic Question
Maiuri, M., Galluzzi, L., Vicencio, J., Kepp, O., Tasdemir, E., & Kroemer, G. (2008) · Current Molecular Medicine · doi:10.2174/156652408783769616 · Cited by 267
Vazquez-Martin, A., Oliveras-Ferraros, C., & Menendez, J. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006251 · Cited by 245
Brehmer, D., Greff, Z., Godl, K., Blencke, S., Kurtenbach, A., Weber, M., Müller, S., Klebl, B., Cotten, M., Kéri, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.379.65.2 · Cited by 241
The anticancer drug imatinib induces cellular autophagy
Ertmer, A., Huber, V, Gilch, S., Yoshimori, T., Erfle, V, Duyster, J., Elsässer, H.-P., & Schätzl, H. M. (2007) · Leukemia · doi:10.1038/sj.leu.2404606 · Cited by 221
John, T., Liu, G., & Tsao, M.-S. (2009) · Oncogene · doi:10.1038/onc.2009.197 · Cited by 207
Autophagy: An emerging target for cancer therapy
Høyer-Hansen, M., & Jäättelä, M. (2008) · Autophagy · doi:10.4161/auto.5921 · Cited by 192 · cited 1×
“tamoxifen) and radiation therapy have been found to induce autophagy in vitro and in vivo [32,33,34].”
BackgroundInvolvement of Protective Autophagy in TRAIL Resistance of Apoptosis-defective Tumor Cells
Han, J., Hou, W., Goldstein, L. A., Lu, C., Stolz, D. B., Yin, X.-M., & Rabinowich, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710169200 · Cited by 181
Li, X., & Fan, Z. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0157 · Cited by 179
Shingu, T., Fujiwara, K., Bögler, O., Akiyama, Y., Moritake, K., Shinojima, N., Tamada, Y., Yokoyama, T., & Kondo, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24030 · Cited by 174
Autophagy inhibition in combination cancer treatment.
Livesey, K. M., Tang, D., Zeh, H. J., & Lotze, M. T. (2009) · PubMed · Cited by 173
Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors
Wu, Z., Chang, P.-C., Yang, J. C., Chu, C.-Y., Wang, L.-Y., Chen, N.-T., Ma, A.-H., Desai, S. J., Lo, S. H., Evans, C. P., et al. (2010) · Genes & Cancer · doi:10.1177/1947601909358324 · Cited by 166
Targeted therapies for non-small cell lung cancer
Dempke, W. C. M., Suto, T., & Reck, M. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.10.012 · Cited by 164
Moore, M. N. (2008) · Autophagy · doi:10.4161/auto.5528 · Cited by 147
Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma
Longo, L., Platini, F., Scardino, A., Alabiso, O., Vasapollo, G., & Tessitore, L. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0361 · Cited by 126
Lung cancer: Progress in diagnosis, staging and therapy
Spiro, S. G., Tanner, N. T., Silvestri, G. A., Janes, S. M., Lim, E. K. S., Vansteenkiste, J., & Pirker, R. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01674.x · Cited by 107
Tiwari, M., Bajpai, V. K., Sahasrabuddhe, A. A., Kumar, A., Sinha, R. A., Behari, S., & Godbole, M. M. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm264 · Cited by 74
The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
Ray, M., Salgia, R., & Vokes, E. E. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0054 · Cited by 63
Cited by
Deconvoluting the context-dependent role for autophagy in cancer
White, E. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3262 · Cited by 1,704
Autophagy modulation as a potential therapeutic target for diverse diseases
Rubinsztein, D. C., Codogno, P., & Levine, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3802 · Cited by 1,437
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.350 · Cited by 1,204
Self-citationTargeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy
Xu, Z., Han, X., Ou, D., Liu, T., Li, Z., Jiang, G., Liu, J., & Zhang, J. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10257-8 · Cited by 612
Wei, Y., Zou, Z., Becker, N., Anderson, M., Sumpter, R., Xiao, G., Kinch, L., Koduru, P., Christudass, C. S., Veltri, R. W., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.015 · Cited by 505
Metadata
- Authors
- Han, W., Pan, H., Chen, Y., Sun, J., Wang, Y., Li, J., Ge, W., Feng, L., Lin, X., Wang, X., Wang, X., & Jin, H.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-06-02
- Volume
- 6
- Issue
- 6
- Pages
- e18691
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2070587415
- Cited by
- 256
- References
- 35
- FWCI
- 13.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.